Qkine secures £1.5M series A funding from leading life science investors
Cambridge, UK 08 June 2020: Qkine – a specialist developer and manufacturer of proteins for stem cell, organoid and regenerative medicine applications […]
News
Qkine secures additional £550K to extend development of R&D pipeline and accelerate commercialisation of product portfolio
Cambridge, UK 03 June 2019: Qkine, specialist manufacturer of proteins for stem cell, organoid and regenerative medicine applications, has closed a […]
So what does the “i” in iteams mean?
Running for over a decade, the iteams programme partners multi-disciplinary teams of PhD students and postdocs with inventors from the University of […]
Building next generation growth factors for organoid-driven precision medicine: a protein engineering project co-funded by Innovate UK
We were delighted to be awarded Innovate UK funding to address issues of quality and availability of growth factors for use in organoid technologies. The Qkine R&D team are applying a combination of protein expression, refolding optimisation and structure-guided protein engineering to improve the biological properties and quality of proteins such as R-spondins, TGFβ1, members of the BMP and FGF family proteins.
Qkine backed by Cambridge Enterprise and a quintet of angels
University of Cambridge spin-out Qkine has closed its seed investment round supported by Cambridge Enterprise, the commercialisation arm of the University, and a […]
Cambridge Enterprise and Qkine Ltd sign deal to drive stem cell and regenerative medicine research
Cambridge Enterprise and specialist growth factor manufacturer Qkine Ltd sign key licensing deal for Activin A production technology